IL141050A0 - Muscarinic agonists and antagonists - Google Patents

Muscarinic agonists and antagonists

Info

Publication number
IL141050A0
IL141050A0 IL14105099A IL14105099A IL141050A0 IL 141050 A0 IL141050 A0 IL 141050A0 IL 14105099 A IL14105099 A IL 14105099A IL 14105099 A IL14105099 A IL 14105099A IL 141050 A0 IL141050 A0 IL 141050A0
Authority
IL
Israel
Prior art keywords
antagonists
muscarinic agonists
muscarinic
agonists
Prior art date
Application number
IL14105099A
Other languages
English (en)
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of IL141050A0 publication Critical patent/IL141050A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL14105099A 1998-08-18 1999-08-16 Muscarinic agonists and antagonists IL141050A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (1)

Publication Number Publication Date
IL141050A0 true IL141050A0 (en) 2002-02-10

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14105099A IL141050A0 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Country Status (30)

Country Link
US (5) US6093724A (sk)
EP (1) EP1112272B1 (sk)
JP (1) JP2002523416A (sk)
KR (1) KR20010072784A (sk)
CN (1) CN1312812A (sk)
AR (1) AR020199A1 (sk)
AT (1) ATE227724T1 (sk)
AU (1) AU750566B2 (sk)
BG (1) BG105256A (sk)
BR (1) BR9913072A (sk)
CA (1) CA2340946A1 (sk)
CO (1) CO5130018A1 (sk)
DE (1) DE69903961T2 (sk)
EE (1) EE200100096A (sk)
ES (1) ES2191455T3 (sk)
HK (1) HK1038918A1 (sk)
HU (1) HUP0103203A3 (sk)
ID (1) ID27544A (sk)
IL (1) IL141050A0 (sk)
IS (1) IS5827A (sk)
NO (1) NO20010804L (sk)
NZ (1) NZ509762A (sk)
PE (1) PE20000988A1 (sk)
PL (1) PL346247A1 (sk)
RU (1) RU2219179C2 (sk)
SK (1) SK1892001A3 (sk)
TR (1) TR200100462T2 (sk)
WO (1) WO2000011001A1 (sk)
YU (1) YU13301A (sk)
ZA (1) ZA200100978B (sk)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2423789A1 (en) * 2000-10-19 2002-04-25 Pfizer Products Inc. Bridged piperazine derivatives
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) * 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
EP2069346B1 (en) 2007-03-23 2011-12-21 Abbott Laboratories Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
CA2679876A1 (en) 2007-03-23 2008-10-02 Abbott Laboratories 4-substituted azaadamantane derivatives and methods of use thereof
WO2010145208A1 (en) * 2009-06-19 2010-12-23 Abbott Laboratories Diazahomoadamantane derivatives and methods of use thereof
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
CA2804215C (en) 2009-07-22 2019-10-01 Eric Elenko Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
BR112013005434A2 (pt) * 2010-09-23 2016-06-07 Abbott Lab novo mono-hidrato de derivados de aza-adamantano
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
WO2019126559A1 (en) 2017-12-20 2019-06-27 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor m4
AU2019346626B2 (en) 2018-09-28 2022-06-02 Karuna Therapeutics, Inc. Compositions and methods for treating disorders ameliorated by muscarinic receptor activation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
WO1992011261A1 (en) * 1990-12-21 1992-07-09 Merck Sharp & Dohme Limited 4-azatricyclo[2.2.1.02,6]heptanes and pharmaceutical compositions
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
HUP9802534A3 (en) * 1995-11-02 1999-06-28 Neurosearch As Fused tropane-derivatives as neurotransmitter reuptake inhibitors
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds

Also Published As

Publication number Publication date
US6555550B1 (en) 2003-04-29
EE200100096A (et) 2002-06-17
EP1112272B1 (en) 2002-11-13
IS5827A (is) 2001-01-26
ZA200100978B (en) 2002-02-05
DE69903961T2 (de) 2003-07-03
HK1038918A1 (zh) 2002-04-04
RU2219179C2 (ru) 2003-12-20
NO20010804D0 (no) 2001-02-16
PL346247A1 (en) 2002-01-28
SK1892001A3 (en) 2001-11-06
EP1112272A1 (en) 2001-07-04
CN1312812A (zh) 2001-09-12
BR9913072A (pt) 2001-05-15
US20020045617A1 (en) 2002-04-18
YU13301A (sh) 2005-06-10
CA2340946A1 (en) 2000-03-02
AU750566B2 (en) 2002-07-25
JP2002523416A (ja) 2002-07-30
PE20000988A1 (es) 2000-09-30
DE69903961D1 (de) 2002-12-19
HUP0103203A2 (hu) 2002-01-28
US6323194B1 (en) 2001-11-27
BG105256A (en) 2001-11-30
WO2000011001A1 (en) 2000-03-02
CO5130018A1 (es) 2002-02-27
TR200100462T2 (tr) 2001-09-21
AU5775899A (en) 2000-03-14
HUP0103203A3 (en) 2002-10-28
US6423842B1 (en) 2002-07-23
US6093724A (en) 2000-07-25
US6251916B1 (en) 2001-06-26
ES2191455T3 (es) 2003-09-01
NO20010804L (no) 2001-04-11
ATE227724T1 (de) 2002-11-15
NZ509762A (en) 2002-12-20
KR20010072784A (ko) 2001-07-31
ID27544A (id) 2001-04-12
AR020199A1 (es) 2002-05-02

Similar Documents

Publication Publication Date Title
PL344407A1 (en) Il-2 selective agonists and antagonists
IL128409A0 (en) Muscarinic antagonists
PL346247A1 (en) Muscarinic agonists and antagonists
GB9812413D0 (en) Compound and its use
HK1042084B (zh) 取代的苯並咪唑及其製備和用途
AU1772300A (en) Glucagon antagonists/inverse agonists
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
GB9813271D0 (en) Composition and use
IL140249A0 (en) Muscarinic antagonists
SG80041A1 (en) Muscarinic receptor antagonists
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
AUPP380498A0 (en) Egf receptor agonists and antagonists
EP1056455A4 (en) EPIMORPHIN COMPOUND AND USE OF THE SAME
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
GB9803232D0 (en) Compound composition and use
HK1043590A1 (zh) 毒蕈碱性拮抗物
AU5861900A (en) Receptor agonists and antagonists
EP1242074A4 (en) NMDA / NR2B ANTAGONISTS BASED ON 5-BENZYL-OCTAHYDROINDOLE AND 6-BENZYL-DECAHYDROQUINOLINE
HUP0004317A3 (en) 5-ht1f agonists
AU9275001A (en) Notch receptor agonists and uses
GB9820014D0 (en) Receptor antagonists and uses thereof
GB9701374D0 (en) Purinergic agonists and antagonists
IL137428A0 (en) Estrogen agonists and antagonists for multiple indications
IL131274A0 (en) Estrogen agonists/antagonists
PL307138A1 (en) Amyline antagonists and agonists